These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22394030)
1. Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma. Rajnai H; Bödör C; Balogh Z; Gagyi E; Csomor J; Krenács T; Tóth E; Matolcsy A Histopathology; 2012 May; 60(6B):E66-75. PubMed ID: 22394030 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. Alvaro T; Lejeune M; Salvadó MT; Lopez C; Jaén J; Bosch R; Pons LE J Clin Oncol; 2006 Dec; 24(34):5350-7. PubMed ID: 17135637 [TBL] [Abstract][Full Text] [Related]
3. Clonal selection in the bone marrow involvement of follicular lymphoma. Bognár A; Csernus B; Bödör C; Reiniger L; Szepesi A; Tóth E; Kopper L; Matolcsy A Leukemia; 2005 Sep; 19(9):1656-62. PubMed ID: 15973453 [TBL] [Abstract][Full Text] [Related]
4. gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes. Braza MS; Caraux A; Rousset T; Lafaye de Micheaux S; Sicard H; Squiban P; Costes V; Klein B; Rossi JF J Immunol; 2010 Jan; 184(1):134-40. PubMed ID: 19949101 [TBL] [Abstract][Full Text] [Related]
5. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma. Richendollar BG; Pohlman B; Elson P; Hsi ED Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493 [TBL] [Abstract][Full Text] [Related]
6. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages. Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621 [TBL] [Abstract][Full Text] [Related]
8. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears. Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113 [TBL] [Abstract][Full Text] [Related]
9. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V; Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786 [TBL] [Abstract][Full Text] [Related]
10. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. Lee AM; Clear AJ; Calaminici M; Davies AJ; Jordan S; MacDougall F; Matthews J; Norton AJ; Gribben JG; Lister TA; Goff LK J Clin Oncol; 2006 Nov; 24(31):5052-9. PubMed ID: 17033038 [TBL] [Abstract][Full Text] [Related]
11. Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement. Cho YU; Chi HS; Park CJ; Jang S; Seo EJ; Huh J Am J Clin Pathol; 2009 May; 131(5):640-6. PubMed ID: 19369622 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of tumor vascularization and microenvironment in follicular lymphoma]. Nesterova ES; Kravchenko SK; Gemdzhian ÉG; Osmanov EA; Kovrigina AM Ter Arkh; 2013; 85(7):57-64. PubMed ID: 24137948 [TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up. Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845 [TBL] [Abstract][Full Text] [Related]
14. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study. Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954 [TBL] [Abstract][Full Text] [Related]
16. Histopathological bone marrow changes after reduced-intensity hematopoietic stem cell transplantation for follicular lymphoma involving bone marrow. Maeda T; Shiozawa E; Saito B; Usui T; Nakashima H; Hattori N; Adachi D; Yanagisawa K; Kawakami K; Nakamaki T; Tomoyasu S; Yamochi-Onizuka T; Takimoto M; Ota H Pathol Int; 2007 Jun; 57(6):378-82. PubMed ID: 17539969 [TBL] [Abstract][Full Text] [Related]
17. Chronic B cell malignancies and bone marrow microenvironment. Ghia P; Granziero L; Chilosi M; Caligaris-Cappio F Semin Cancer Biol; 2002 Apr; 12(2):149-55. PubMed ID: 12027587 [TBL] [Abstract][Full Text] [Related]
18. Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay. Hanamura A; Kinoshita T; Kurokawa T; Nagai H; Murate T; Nagasaka T; Mori H; Saito H Int J Hematol; 1999 Dec; 70(4):283-9. PubMed ID: 10643155 [TBL] [Abstract][Full Text] [Related]